| Fund ID | 805-6259659957 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 86% |
| Fund | Type | Gross assets |
|---|---|---|
| Health Catalyst Capital II, L.P. | Private Equity | $137.1M |
| Health Catalyst Capital, L.P. | Private Equity | $135.4M |
| Health Catalyst Capital Continuation Fund I, L.P. | Private Equity | $64M |
Hcc Coinvest Qbd 18, L.P. reports $277,120 in gross assets, among the top 97% of private funds by size.
The stated minimum investment is $34,541.
Hcc Coinvest Qbd 18, L.P. is managed by Health Catalyst Capital Management, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.